aTyr Pharma, Inc. announced that James C. Blair, Ph.D. completed his term as a director of the Company and did not stand for reelection when his term as a Class II director expired at the Company’s 2020 Annual Meeting of Stockholders held on May 6, 2020. Dr. Blair previously served as a member of the Company’s Compensation Committee and Nominating and Corporate Governance Committee. Dr. Blair’s decision not to stand for reelection was not a result of a disagreement with management regarding the Company’s operations, policies, practices or otherwise.